Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

Overview of attention for article published in BMC Genomic Data, September 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 1,491 followers.

We've detected a paper from BMC Genomic Data that cites a retracted paper post-retraction. Citing paper: https://t.co/2W4r7DkzHL Retracted paper: https://t.co/AkplgckC5Y

We've detected a paper from BMC Genomic Data that cites a retracted paper post-retraction. Citing paper: https://t.co/2W4r7DkzHL Retracted paper: https://t.co/iuiJSPXx7T

New article: Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy https://t.co/b3ul3zuKop #breastcancer #oncology https://t.co/pCpECoxEHH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.